Anthropic says Claude AI helped discover novel enzyme system
Tweet
Share
E-mail
FILE PHOTO: The Anthropic logo, a keyboard and a robotic hand are shown in this illustration created on June 5, 2026. REUTERS/Dado Ruvic/File Photo
Sept 23 (Reuters) - Anthropic on Wednesday said its Claude model helped discover a novel enzyme system with properties reminiscent of mechanisms in gene-editing technology CRISPR, marking the first result from the AI startup's biology research efforts.
The finding comes days after Reuters reported Anthropic had quietly established a wet lab in the San Francisco Bay Area, as the company expands its ambitions in life sciences and drug-related research beyond purely computer-based work.
• Anthropic said Claude analyzed large DNA databases and found an unusual system built around a reverse transcriptase (RT), an enzyme that copies RNA into DNA.
• Anthropic has named the system array-associated reverse transcriptases, or ART.
• ART contains repeating DNA sequences that resemble patterns seen in CRISPR, Anthropic said.
• The company noted that while the underlying RT had been identified in previous studies, Claude appeared to be the first to recognize key features of the broader system, including an array of non-coding DNA sequences and an additional protein of unknown function.
(Reporting by Aatreyee Dasgupta in Bengaluru; Editing by Jonathan Ananda)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Modal Labs in talks to raise funds at $15 billion valuation, Bloomberg News reports
- Wells Fargo's chief risk officer Derek Flowers to retire
- AI firms should not get regulatory waivers, Nvidia CEO says on podcast
Create E-mail Alert Related Categories
ReutersSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
